Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Anixa Biosciences Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
ANIX (Anixa Biosciences Inc) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
63 institutional managers report a position in Anixa Biosciences Inc worth $15.0M between them, filed on form 13F for the quarter ending 2026-06-30. 10 of them hold 80% of it, the largest being Vanguard Capital Management LLC at 24.85%.
38 more managers in the register
10 managers hold 80% of the $15.0M institutional base. The other 53 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Marshall Wace LLP, GSA Capital Partners LLP, AXQ Capital, LP · 6.13% of ANIX, 6.41% of VNCE
via Marshall Wace LLP, GSA Capital Partners LLP, Group One Trading, L.P. · 6.13% of ANIX, 12.01% of FLNA
via Marshall Wace LLP, GSA Capital Partners LLP, CI Private Wealth, LLC · 6.13% of ANIX, 5.65% of ARQ
via Marshall Wace LLP, GSA Capital Partners LLP · 6.13% of ANIX, 6.48% of TNYA
via Marshall Wace LLP, GSA Capital Partners LLP · 6.13% of ANIX, 21.88% of GANX
via Marshall Wace LLP, GSA Capital Partners LLP · 6.13% of ANIX, 17.44% of STEM
Managers holding a meaningful stake in ANIX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.